Management of Acute Asthma Exacerbation
The management of acute asthma exacerbation requires immediate administration of oxygen, inhaled short-acting beta-agonists (SABAs), and systemic corticosteroids as the primary treatment, with severity assessment determining the intensity and frequency of interventions. 1
Initial Assessment and Classification
Features of Severe Asthma
- Too breathless to complete sentences in one breath
- Respiratory rate >25 breaths/min
- PEF <50% of predicted normal or best
- Heart rate >110 beats/min 1
Life-Threatening Features
- PEF <33% of predicted normal or best
- Silent chest, cyanosis, or feeble respiratory effort
- Bradycardia or hypotension
- Exhaustion, confusion, or coma 1
Step-by-Step Management Algorithm
1. Oxygen Therapy
- Administer supplemental oxygen through nasal cannulae or mask
- Maintain SaO₂ >90% (>95% in pregnant women and patients with heart disease)
- Monitor oxygen saturation until clear response to bronchodilator therapy 1
2. Inhaled Short-Acting Beta-Agonists (SABAs)
- First-line treatment: High-dose inhaled beta-agonists
- Administer salbutamol 5 mg or terbutaline 10 mg via nebulizer with oxygen
- Alternative: Multiple actuations (4-12 puffs) of SABA via MDI with spacer device 1
- Initial strategy: 3 treatments every 20-30 minutes, then adjust frequency based on response
- For severe exacerbations (FEV₁ or PEF <40% predicted): Consider continuous nebulization 1
3. Systemic Corticosteroids
- Administer early to all patients with moderate-to-severe exacerbations
- Oral prednisolone 30-60 mg daily until lung function returns to previous best (usually 7 days, may need up to 21 days) 1
- IV hydrocortisone 200 mg is an alternative for patients who are seriously ill or vomiting 1
- Early administration may reduce hospitalization rates 1
4. Inhaled Ipratropium Bromide (Anticholinergic)
- Add to SABA therapy for severe exacerbations to increase bronchodilation
- Dosage: 0.5 mg nebulizer solution or 8 puffs via MDI in adults
- The combination of SABA and ipratropium has been shown to reduce hospitalizations, particularly in severe airflow obstruction 1, 2
5. Monitoring and Reassessment
- Measure PEF 15-30 minutes after starting treatment and thereafter according to response
- Repeat assessment after initial dose of bronchodilator for severe exacerbations
- All patients should be reassessed after 3 doses of bronchodilator (60-90 minutes after initiation) 1
- Response to treatment is a better predictor of need for hospitalization than initial severity 1
6. Additional Investigations (If Hospitalized)
- Arterial blood gas analysis for patients with severe exacerbations
- Chest radiography to exclude pneumothorax, consolidation, or pulmonary edema
- Plasma electrolytes, urea concentrations, and blood count 1
Management Based on Response
Improving Condition
- Continue oxygen therapy
- Continue systemic corticosteroids
- Give nebulized beta-agonist every 4 hours 1
Not Improving After 15-30 Minutes
- Give nebulized beta-agonists more frequently (up to every 15 minutes)
- Consider adding IV aminophylline (250 mg over 20 minutes) or IV salbutamol/terbutaline (250 μg over 10 minutes)
- Caution: Do not give bolus aminophylline to patients already taking oral theophyllines 1
Impending Respiratory Failure (Warning Signs)
- Inability to speak
- Altered mental status
- Intercostal retraction
- Worsening fatigue
- PaCO₂ ≥42 mm Hg 1
Common Pitfalls and Caveats
Underestimation of severity: The severity of asthma exacerbations is often underestimated by patients, relatives, and doctors due to failure to make objective measurements 1
Delayed corticosteroid administration: Systemic corticosteroids should be given early as clinical benefits may not occur for 6-12 hours 3
Inappropriate antibiotic use: Antibiotics are not generally recommended as viruses are a much more common cause of exacerbations. Reserve for cases with strong evidence of bacterial infection (pneumonia, sinusitis) 1
Paradoxical bronchospasm: In rare cases, SABAs can cause paradoxical bronchospasm. If this occurs, consider switching to anticholinergic agents 4
Sedation: Any sedation is contraindicated in acute asthma exacerbations 1
Excessive hydration: Aggressive hydration is not recommended for older children and adults but may be appropriate for some infants and young children 1
Criteria for Hospital Admission
- Any life-threatening features
- Any features of severe attack that persist after initial treatment
- PEF <33% of predicted or best value 15-30 minutes after nebulization
- Lower threshold for admission in patients:
- Seen later in the day
- With recent nocturnal symptoms
- With previous severe attacks
- With poor social support 1
By following this systematic approach to managing acute asthma exacerbations, clinicians can effectively reduce morbidity and mortality while optimizing patient outcomes.